Pancreatite e cetoacidose diabética numa adolescente tratada com sertralina

Detalhes bibliográficos
Autor(a) principal: Ferreira, Ana Maria
Data de Publicação: 2020
Outros Autores: Caldeira Santos, Joana, Ferreira, Sofia, Leite, Ana Luísa, Campos, Rosa Arménia
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.16/2611
Resumo: Acute pancreatitis (AP) is a rare entity in pediatric age. Reports of AP in the context of diabetic ketoacidosis (DKA) have established the role of transient hyperlipemia as a consequent factor. Pharmacological etiology is responsible for 0.3−1.4% of AP cases, with no case reports of an association with the use of sertraline in the pediatric population to date. Herein is described the case of a 15-year-old girl with poorly controlled type 1 diabetes, taking sertraline for a depressive disorder, who developed AP associated with DKA. With this report, the authors intend to emphasize the importance of diagnosing AP in DKA setting. In addition, since the patient had normal serum triglyceride levels and no other risk factors for AP, it is hypothesized that sertraline may have been a triggering event in this context.
id RCAP_58af1689d7d582720c6f1909a5a4e9b6
oai_identifier_str oai:repositorio.chporto.pt:10400.16/2611
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Pancreatite e cetoacidose diabética numa adolescente tratada com sertralinaPancreatite e cetoacidose diabética numa adolescente tratada com sertralinaacute pancreatitisadolescentdiabetic ketoacidosissertralinethyroiditisAcute pancreatitis (AP) is a rare entity in pediatric age. Reports of AP in the context of diabetic ketoacidosis (DKA) have established the role of transient hyperlipemia as a consequent factor. Pharmacological etiology is responsible for 0.3−1.4% of AP cases, with no case reports of an association with the use of sertraline in the pediatric population to date. Herein is described the case of a 15-year-old girl with poorly controlled type 1 diabetes, taking sertraline for a depressive disorder, who developed AP associated with DKA. With this report, the authors intend to emphasize the importance of diagnosing AP in DKA setting. In addition, since the patient had normal serum triglyceride levels and no other risk factors for AP, it is hypothesized that sertraline may have been a triggering event in this context.Centro Hospitalar Universitário do PortoRepositório Científico do Centro Hospitalar Universitário de Santo AntónioFerreira, Ana MariaCaldeira Santos, JoanaFerreira, SofiaLeite, Ana LuísaCampos, Rosa Arménia2021-11-23T11:07:36Z2020-122020-12-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.16/2611engFerreira AM, Caldeira-Santos J, Ferreira S, Leite AL, Campos RA, Nascer e Crescer - Birth and Growth Medical Journal 2020;29(4): 209-211. doi:10.25753/BirthGrowthMJ.v29.i4.179342183-941710.25753/BirthGrowthMJ.v29.i4.17934info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-10-20T11:01:19Zoai:repositorio.chporto.pt:10400.16/2611Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:38:48.853633Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Pancreatite e cetoacidose diabética numa adolescente tratada com sertralina
Pancreatite e cetoacidose diabética numa adolescente tratada com sertralina
title Pancreatite e cetoacidose diabética numa adolescente tratada com sertralina
spellingShingle Pancreatite e cetoacidose diabética numa adolescente tratada com sertralina
Ferreira, Ana Maria
acute pancreatitis
adolescent
diabetic ketoacidosis
sertraline
thyroiditis
title_short Pancreatite e cetoacidose diabética numa adolescente tratada com sertralina
title_full Pancreatite e cetoacidose diabética numa adolescente tratada com sertralina
title_fullStr Pancreatite e cetoacidose diabética numa adolescente tratada com sertralina
title_full_unstemmed Pancreatite e cetoacidose diabética numa adolescente tratada com sertralina
title_sort Pancreatite e cetoacidose diabética numa adolescente tratada com sertralina
author Ferreira, Ana Maria
author_facet Ferreira, Ana Maria
Caldeira Santos, Joana
Ferreira, Sofia
Leite, Ana Luísa
Campos, Rosa Arménia
author_role author
author2 Caldeira Santos, Joana
Ferreira, Sofia
Leite, Ana Luísa
Campos, Rosa Arménia
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Repositório Científico do Centro Hospitalar Universitário de Santo António
dc.contributor.author.fl_str_mv Ferreira, Ana Maria
Caldeira Santos, Joana
Ferreira, Sofia
Leite, Ana Luísa
Campos, Rosa Arménia
dc.subject.por.fl_str_mv acute pancreatitis
adolescent
diabetic ketoacidosis
sertraline
thyroiditis
topic acute pancreatitis
adolescent
diabetic ketoacidosis
sertraline
thyroiditis
description Acute pancreatitis (AP) is a rare entity in pediatric age. Reports of AP in the context of diabetic ketoacidosis (DKA) have established the role of transient hyperlipemia as a consequent factor. Pharmacological etiology is responsible for 0.3−1.4% of AP cases, with no case reports of an association with the use of sertraline in the pediatric population to date. Herein is described the case of a 15-year-old girl with poorly controlled type 1 diabetes, taking sertraline for a depressive disorder, who developed AP associated with DKA. With this report, the authors intend to emphasize the importance of diagnosing AP in DKA setting. In addition, since the patient had normal serum triglyceride levels and no other risk factors for AP, it is hypothesized that sertraline may have been a triggering event in this context.
publishDate 2020
dc.date.none.fl_str_mv 2020-12
2020-12-01T00:00:00Z
2021-11-23T11:07:36Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.16/2611
url http://hdl.handle.net/10400.16/2611
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Ferreira AM, Caldeira-Santos J, Ferreira S, Leite AL, Campos RA, Nascer e Crescer - Birth and Growth Medical Journal 2020;29(4): 209-211. doi:10.25753/BirthGrowthMJ.v29.i4.17934
2183-9417
10.25753/BirthGrowthMJ.v29.i4.17934
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Centro Hospitalar Universitário do Porto
publisher.none.fl_str_mv Centro Hospitalar Universitário do Porto
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133648468836352